Prevention of Type II diabetes in subjects with impaired glucose tolerance: The Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme

Diabetologia

Volumn 42, Issue 7, 1999, Pages 793-801

  Eriksson, J ^a   Lindstrom J ^a   Valle, T ^a   Aunola, S ^b   Hamalainen H ^b   Ilanne Parikka, P ^c   Keinanen Kiukaanniemi S ^d   Laakso, M ^d   Lauhkonen, M ^e   Lehto, P ^e   Lehtonen, A ^f   Louheranta, A ^g   Mannelin, M ^h   Martikkala, V ^h   Rastas, M ^b   Sundvall, J ^a   Turpeinen, A ^g   Viljanen, T ⁱ   Uusitupa, M ^g   Tuomilehto, J ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c Finnish Diabetes Association   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e Institute of Nursing and Health Care   (Finland)

^f UNIVERSITY OF TURKU   (Finland)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

^h OULU DEACONESS INSTITUTE   (Finland)

ⁱ Paavo Nurmi Centre   (Finland)

Author keywords

Blood pressure; Diet; Glucose; Impaired glucose tolerance; Lipids; Obesity; Physical activity; Primary prevention; Type II diabetes mellitus; Weight

Indexed keywords

GLUCOSE; LIPID; SATURATED FATTY ACID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DIETARY FIBER; EXERCISE; FEASIBILITY STUDY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; WEIGHT REDUCTION;

EID: 0032791143     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051229     Document Type: Article

References (55)

1. 1. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038
2. 2. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1983) Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. BMJ 287: 867-870
3. 3. Manson JE, Colditz GA, Stampfer MJ et al. (1991) A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 151: 1141-1147
4. 4. Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328: 1676-1685
5. 5. Stamler J, Vaccaro O, Neaton J, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444
6. 6. Rubin RJ, Altman WM, Mendelson DN (1994) Health care expenditures for people with diabetes mellitus. J Clin Endocrinol Metab 78: 809A-809F
7. 7. Kangas T, Aro S, Koivisto VA et al. (1996) Structure and costs of health care of diabetic patients in Finland. Diabetes Care 19: 494-497
8. 8. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703-713
9. 9. UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853
10. 10. Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 14: S7-S85
11. 11. Tuomilehto J, Tuomilehto-Wolf E, Zimmet P, Alberti KGMM, Knowler WC (1997) Primary prevention of diabetes mellitus. In: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H (eds) International Textbook of Diabetes Mellitus, 2nd edn. Wiley, Chichester New York Brisbane Toronto, pp 1799-1827
12. 12. Hamman RF (1992) Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8: 287-338
13. 13. Eriksson J, Franssila-Kallunki A, Ekstrand A et al. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337-343
14. 14. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909-915
15. 15. Harris MI (1989) Impaired glucose tolerance in the U. S. population. Diabetes Care 12: 464-474
16. 16. Stengård JH, Tuomilehto J, Pekkanen J et al. (1992) Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: The Finnish cohorts of the Seven Countries Study. Diabetologia 35: 760-765
17. 17. Knowler WC, Sartor G, Melander A, Schersten B (1997) Glucose tolerance and mortality, including a substudy of tolbutamide treatment. Diabetologia 40: 680-686
18. 18. Valle T, Tuomilehto J, Eriksson J (1997) Epidemiology of NIDDM in Europids. In: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H (eds) International textbook of diabetes mellitus, 2nd edn. Wiley, Chichester New York Brisbane Toronto, pp 125-142
19. 19. Joslin EP (1921) The prevention of diabetes mellitus. JAMA 76: 79-84
20. 20. World Health Organisation (1994) Primary prevention of diabetes mellitus. Technical Report Series No 844, WHO, Geneva
21. 21. Fajans SS, Conn JW (1960) Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus. Diabetes 9: 83-88
22. 22. Paasikivi J (1970) Long-term tolbutamide treatment after myocardial infarction. Acta Med Scand; [Suppl] 507
23. 23. Sartor G, Schersten B, Carlstrom S, Melander A, Norden A, Persson G (1980) Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes 29: 41-49
24. 24. Keen H, Jarrett RJ, McCartney P (1982) The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22: 73-78
25. 25. Ratzmann KP, Witt S, Schulz B (1983) The effect of long-term glibenclamide treatment on glucose tolerance, insulin secretion and serum lipids in subjects with impaired glucose tolerance. Diabetes Metab 9: 87-93
26. 26. Jarrett RJ, Keen H, McCartney P (1984) The Whitehall study: ten year follow-up report on men with impaired glucose tolerance with reference to worsening to diabetes and predictors of death. Diabet Med 1: 279-283
27. 27. Eriksson KF, Lindgärde E (1991) Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: The 6-year Malmö feasibility study. Diabetologia 34: 891-898
28. 28. Pan X-P, Li G-W, Hu Y-H et al. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-544
29. 29. Tuomilehto J, Korhonen HJ, Kartovaara L et al. (1991) Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. Int J Epidemiol 20: 1010-1017
30. 30. Matthews DR, Hosker JP, Rudenski AS et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419
31. 31. Valle T, Tuomilehto J, Bergman RN et al. (1998) Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care 21: 949-958
32. 32. World Health Organization Expert Committee (1985) Diabetes Mellitus. Technical Report Series No 742, WHO, Geneva
33. 33. Norman GR, Streiner DL (1994) Biostatistics. The bare essentials. Mosby, St Louis Baltimore Boston Chicago London Madrid Philadelphia Sydney Toronto
34. 34. Sarkkinen E, Schwab U, Niskanen L et al. (1996) The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance. Eur J Clin Nutr 50: 592-598
35. 35. Prineas RJ, Crow RS, Blackburn H (1982) The Minnesota code manual of eloectrocardiographic findings. Laboratory of Physiological Hygiene, School of Public Health, University of Minnesota
36. 36. Lakka T (1994) Leisure time physical activity, cardiorespiratory fitness, biological coronary risk factors and coronary heart disease: a population study in men in eastern Finland. Academic Doctoral Dissertation. Kuopio, Finland. Kuopio University Printing Office
37. 37. Oja P, Laukkanen R, Pasanen M, Tyry T, Vuori I (1991) A 2-km walking test for assessing the cardiorespiratory fitness of healthy adults. Int J Sports Med 12: 356-362
38. 38. Laukkanen R, Oja P, Pasanen M, Vuori I (1992) Validity of a two kilometre walking test for estimating maximal aerobic power in overweight adults. Int J Obes Relat Metab Disord 16: 263-268
39. 39. Pietinen P, Hartman AM, Haapa E et al. (1988) Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 128: 655-666
40. 40. Haapa E, Toponen T, Pietinen P, Räsänen L (1985) Annoskuvakirja. Painokaari Oy, Helsinki
41. 41. Ovaskainen M-L, Valsta L, Lauronen J (1996) The compilation of food analysis values as a database for dietary studies - the Finnish experience. Food Chemistry 57: 133-136
42. 42. Hays RD, Donald Sherbourne C, Mazel RM (1993). The RAND 36-Item Health Survey 1.0. Health Econ 2: 217-227
43. 43. Bourn D, Mann J, McSkimming B, Waldron M, Wishart J (1994) Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect? Diabetes Care 17: 1311-1319
44. 44. Knowler WC, Narayan KM, Hanson RL et al. (1995) Preventing non-insulin-dependent diabetes. Diabetes 44: 483-488
45. 45. Chiasson J-L, Josse RG, Leiter LA et al. (1995) Can we prevent the development of non-insulin-dependent diabetes mellitus (abstract). Diabetes 44 [Suppl 1]:62 A
46. 46. National Institutes of Health (1993) Non-insulin dependent diabetes primary prevention trial. NIH guide grants contratcs 22: 1-20
47. 47. Page RCL, Harnden KE, Walravens NKN et al. (1993) 'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular diseases in subjects with impaired glucose tolerance QJM 86: 145-154
48. 48. Alberti KGMM (1996) The clinical implications of impaired glucose tolerance. Diabet Med 13: 927-937
49. 49. Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P (1997). Lifestyle changes may reverese development of the insulin resistance syndrome. Diabetes Care 20: 26-31
50. 50. Uusitupa MIJ (1996) Early lifestyle intervention in patients with non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Ann Med 28: 445-449
51. 51. Page RCL, Harnden KE, Cook JTE, Turner RC (1992) Can life-styles of subjects with impaired glucose tolerance be changed? A feasibility study. Diabet Med 9: 562-566
52. 52. Laitinen JH, Ahola IE, Sarkkinen ES, Winberg RL, Harmaakorpi-Iivonen PA, Uusitupa MI (1993) Impact of intensified dietary therapy on energy and nutrient intakes and fatty acid composition of serum lipids in patients with recently diagnosed non-insulin-dependent diabetes mellitus. J Am Diet Assoc 93: 276-283
53. 53. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36: 1175-1184
54. 54. Vague J (1956) Degree of masculine differentiation of obesities: factor determinating predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 4: 220-234
55. 55. Pi-Sunyer FX (1993) Medical hazards of obesity. Ann Intern Med 119: 655-660